A business in context

OCUL research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-14 · 0001104659-26-116617 · Items 5.02

  2. 4 · Ownership change

    Report date 2026-10-08 · 0001104659-26-115551

  3. 4 · Ownership change

    Report date 2026-10-02 · 0001104659-26-114081

  4. 4 · Ownership change

    Report date 2026-10-02 · 0001104659-26-114080

  5. 4 · Ownership change

    Report date 2026-08-31 · 0001104659-26-104727

  6. 4 · Ownership change

    Report date 2026-08-24 · 0001104659-26-101674

  7. 4 · Ownership change

    Report date 2026-08-24 · 0001104659-26-101671

  8. 4 · Ownership change

    Report date 2026-08-24 · 0001104659-26-101670

  9. 4 · Ownership change

    Report date 2026-08-24 · 0001104659-26-101667

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-089450

  11. 8-K · Current report

    Report date 2026-08-03 · 0001104659-26-089443 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-06-10 · 0001104659-26-073496 · Items 5.02,5.07,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-055256

  14. 8-K · Current report

    Report date 2026-05-05 · 0001104659-26-055241 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001104659-26-053176

  16. 8-K · Current report

    Report date 2026-02-27 · 0001104659-26-021541 · Items 7.01

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-010664

  18. 8-K · Current report

    Report date 2026-02-05 · 0001104659-26-010633 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-20 · 0001104659-26-006015 · Items 5.02

  20. 8-K · Current report

    Report date 2025-12-18 · 0001104659-25-122564 · Items 8.01

  21. 8-K · Current report

    Report date 2025-12-05 · 0001104659-25-118940 · Items 8.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-105919

  23. 8-K · Current report

    Report date 2025-11-04 · 0001104659-25-105914 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-09-30 · 0001104659-25-094758 · Items 1.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-09-30 · 0001104659-25-094724 · Items 8.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010177

  27. 8-K · Current report

    Report date 2025-08-05 · 0001104659-25-073909 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-11 · 0001104659-25-058525 · Items 5.02,5.03,5.07,8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-006225

  30. 8-K · Current report

    Report date 2025-05-05 · 0001104659-25-044349 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-11 · 0001558370-25-005868

  32. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-002000

  33. 8-K · Current report

    Report date 2025-03-03 · 0001104659-25-019462 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-02-11 · 0001104659-25-013473 · Items 5.02

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001558370-24-015613

  36. SC 13G/A · Ownership disclosure

    0001104659-24-119330

  37. 8-K · Current report

    Report date 2024-11-14 · 0001104659-24-118284 · Items 2.02,9.01

  38. SC 13G · Ownership disclosure

    0000902664-24-006529

  39. SC 13G/A · Ownership disclosure

    0000932471-24-001144

  40. SC 13G/A · Ownership disclosure

    0002012383-24-003477

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 2 transaction rows2G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

7 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-31
2026-09-02
Notman DonaldS · Sale
Disposed
Common Stock1099.010.24
2026-08-25
2026-08-26
Dugel Pravin
10b5-1 checkbox reported
G · Gift
Acquired
Common Stock50092.00.0
2026-08-25
2026-08-26
Dugel Pravin
10b5-1 checkbox reported
G · Gift
Disposed
Common Stock50092.00.0
2026-08-24
2026-08-26
Kaiser Peter
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3035.010.77
2026-08-24
2026-08-26
Nayak Sanjay
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1897.010.78
2026-08-24
2026-08-26
Heier Jeffrey S.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3296.010.78
2026-08-24
2026-08-26
Dugel Pravin
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock21649.010.77

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001393434OCULAR THERAPEUTIX, INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • I-THERAPEUTIX INC · former SEC name · 2007-03-06 to 2009-07-02

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$63.72M$68.44M
2023-12-31$58.44M$64.62M
2022-12-31$51.49M$59.28M
2021-12-31$43.52M$54.11M
2020-12-31$17.40M$22.66M
2019-12-31$4.23M$5.57M
2018-12-31$1.99M$2.67M
2017-12-31$1.92M$2.64M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗